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Cow’s milk protein elimination in autistic children: language, cognitive    
and behavioral outcome.  
 
INTRODUCTION 
Autism, or rather autism spectrum disorders (ASD), 
is a childhood psychiatric problem characterized by 
a qualitative impairment in verbal and non-verbal 
communication, in imaginative activity, and in 
reciprocal interactions1. It is the most prevalent of a 
subset of disorders organized under the umbrella of 
pervasive developmental disorder (PDD)2. This 
neurodevelopmental disorder has many biological 
causes, including genetic, syndromic and 
environmental3.  
Some authors have previously suggested that 
food peptides might be able to determine toxic 
effects at the level of the central nervous system 
(CNS) by interacting with neurotransmitters. In 
fact, a worsening of neurological symptoms has 
been reported in autistic patients after the 
consumption of milk and wheat4. The suggested 
toxins are the Casomorphins and Gliadomorphins 
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which are families of exorphins (structurally similar 
to endorphins) released from the partial digestion of 
the milk protein casein and the wheat protein 
gliadin5. They are potent psychosis-inducing 
factors6. 
Jyonouchi et al7 suggested another mechanism 
for adverse effects of cow's milk protein (CMP) in 
autistic children. They stated that immune reactivity 
to dietary proteins including CMP may be 
associated with apparent dietary protein intolerance 
and gastrointestinal (GI) inflammation in ASD. 
This may be partly associated with an aberrant 
innate immune response against endotoxin, a 
product of the gut bacteria. Additionally, Jyonouchi 
et al8 reported a positive association between TNF-
alpha levels produced with endotoxins that 
stimulate innate immunity in the gut mucosa and 
those with CMP and its major components 
regardless of dietary interventions in ASD children 
who suffer GI symptoms. They concluded that 
intrinsic defects of innate immune responses are 
present in such children and this could offer an 
explanation to the link between GI and behavioral 
symptoms in ASD. Immune changes were reported 
in autistic children previously by Tomoum and 
associates9. 
This study was designed to assess the degree of 
benefit in various aspects of development of autistic 
children upon elimination of CMP from their diet 
and the possible correlation between CMP specific 





The current study was conducted on 22 autistic 
children recruited from the Phoniatrics Unit and 
Psychiatric Outpatient Clinic, Ain Shams 
University Hospitals, Cairo, Egypt during the 
period from April, 2005 till March 2006. The 
recruited children fitted the criteria for diagnosis of 
autism according to the DSM IV10. Additionally, 
the diagnosis was confirmed and the patients were 
categorized based on their Childhood Autism 
Rating Scale (CARS) test score. They were 12 
males and 10 females with an age range of 2.5 to 10 
years (mean = 5.8 ± 2.4 years). The patients were 
compared to 30 healthy age and sex matched 
children enrolled as a control group. These were 17 
males and 13 females with an age range of 2 to 8.5 
years (mean = 5.9 ± 2.7 years). 
After obtaining the approval of the local Ethical 
Committee at the Children’s Hospital, Ain Shams 
University, each parent or caregiver gave an 
informed consent before participation in the study. 
We ensured that the enrolled autistic children were 
on no medications during the whole study period. 
The patients were randomly assigned to one of two 
groups. The parents or caregivers of the first group 
(11 patients, 6 males and 5 females with an age 
range of 3 to 10 years) were instructed to eliminate 
CM from the diet of their children throughout the 
study period while those of the second group were 
allowed to feed their children without restrictions. 
The second group included 11 autistic patients, 6 




Each patient was subjected to linguistic and 
developmental history taking as well as a 
comprehensive multidisciplinary complete 
psychiatric history taking. Dietetic history was also 
taken with a 24 hours recall of feeding to ensure 
that all autistic children met their recommended 
daily dietary allowances especially for calcium. 
Anthropometric measurements were taken and 
compared to the normal percentiles of growth11. 
Clinical examination was performed to detect any 
clinical evidence of atopic disease. CARS test was 
applied to ascertain the diagnosis of autistic 
disorder and determine its degree and a child 
psychiatric evaluation was performed. Venous 
blood samples were then withdrawn for laboratory 
procedures. The patients were finally subjected to 
language, intelligent quotient (IQ), social and 
mental age assessment. 
Follow up 
The children who participated in this work received 
interventional individual language therapy sessions 
and behavioral therapy in a semi-structured play 
situation; both therapeutic modules were 
administered concomitantly for six months, 
twice/week regularly. Each session was 20 minutes 
long. Both the language and behavioral therapy 
sessions progressed through different stages 
including attention control, manual activities to 
build up cognitive abilities and inner language and 
training to improve the language aptitudes aiming at 
increasing the size of the passive and active 
vocabulary. Clinical reevaluation of the patients 
was done at the end of the six months follow up 
including repetition of the language, social, mental 
age and IQ assessment. 
Proper growth rates occurred in both groups 
and the autistic patients were within normal 
percentiles for age and sex throughout the whole 
study period. No clinical evidence of any nutritional 
deficiency was noticed in patients of either group 
during the 6 months follow up. 
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Serum CM specific IgE assay 
Blood was collected from each patient or control 
upon enrollment by venipuncture under complete 
aseptic condition and was allowed to clot. Serum 
was separated by centrifugation at room 
temperature at 1500 rpm for 10 min and was stored 
at -20ºC for later quantitative determination of 
specific IgE to CM antigen. All samples were 
assayed in the same setting using an enzyme 
immunoassay kit (R-Biopharm GmbH, Darmstadt, 
Germany). 
Childhood Autism Rating Scale 
Childhood Autism Rating Scale (CARS), as 
explained by Schopler et al12 is a test for 
identification of autism. It gives an accurate 
diagnosis by the age of 3 years. This test can be 
used to determine the severity of autistic 
symptomatology and can thus be useful in its 
periodic monitoring13. CARS test consists of 15 
items, each rated on a 4-point scale (may be 
extended to 7 points by insertion of intermediate 
points). The child may be rated between two 
descriptions by using rating of 1.5, 2.5 or 3.5.   
The 15 items include;  
1. Relating to people. 
2. Imitation. 
3. Emotional response. 
4. Body use. 
5. Object use. 
6. Adaptation to change. 
7. Visual response. 
8. Listening response. 
9. Taste, smell and touch response and use. 
10.  Fear or nervousness. 
11.  Verbal communication. 
12.  Non verbal communication. 
13.  Activity level. 
14.  Level and consistency of intellectual response. 
15.  General impressions. 
The total score of the test can range from 15 to 
60 points according to the severity of autism. The 
score can be categorized into: non-autistic (15-29 
points) as grade 0, mild to moderately autistic (30-
36 points) as grade 1 and severely autistic (37-60 
points) as grade 2. 
Language assessment 
Standardized Arabic language test was used in the 
current study14. This test is used to evaluate the 
language age of the child from zero to 8 years by 
assessing the child's attention through observation, 
the receptive and expressive part of the sementics, 
the receptive and expressive part of the syntax, the 
prosody, the pragmatics and the phonology. 
 
 
Social age determination 
Social age was determined by the Vineland Social 
Maturity Scale of Doll15. This scale is applied to 
assess the social behavior and abilities of the 
children and is suitable for children from birth to 15 
years. 
Mental age determination 
Mental age was assessed by Stanford-Binet test16. 
This test is used to measure the child's cognitive 
abilities. It is suitable for children aging from 2-16 
years. The test has two items, the verbal and the 
performance and the test item is chosen according 
to the child's abilities. Intelligence quotient (IQ) is 
calculated by dividing the mental age by the 
chronological age multiplied by 100. 
 
Statistical analysis 
Statistical analysis of the results was done via a 
standard computer programs SPSS (version 10) and 
Statistica software package version 5 (Statsoft, 
Tulsa, OK, USA). Non-parametric data were 
verified by the Kolmogorov-Smirnov test.  The 
numerical data were presented as mean + SD as 
well as median and interquartile range (IQR). 
Student-t test was used for comparing parametric 
data and Mann-Whitney U tests for non-parametric 
data. Paired-t test was used to compare parametric 
values after follow up while Wilcoxon Signed 
Ranks test was employed for non-parametric ones. 
Numeric variables were also related by correlation 
coefficient tests. The relations were considered 




Table (1) shows that the studied groups of autistic 
children were comparable in terms of initial CARS 
test results, language, social age, mental age and IQ 
(p>0.05). This table also demonstrates significantly 
lower CARS (p<0.01) and significantly higher 
language age (p<0.05) in the group that underwent 
CM elimination diet compared to the other group 
after 6 months follow up. Significantly higher rates 
of change of CARS test results, language, social 
age, mental age and IQ in the CM elimination diet 
group were also detected as compared to the other 
group by the end of the trial (p<0.001, p<0.05, 
p<0.05, p<0.01 and p<0.05 respectively). 
A significant decrease in CARS test results in 
both groups of autistic children is displayed in table 
(2) yet more evident in the first group. Concerning 
the language age, only the first group showed 
significant improvement on follow up (p = 0.01 and 
p>0.05 respectively). Both the social and mental 
ages improved in the first group only (p< 0.01 and 
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p>0.05 respectively). Although the IQ values 
seemed higher after 6 months in the autistic patients 
who were on CM elimination diet, the difference 
did not reach statistical significance (p>0.05). 
Figure (1) shows significantly higher specific 
IgE levels against CMP in the autistic patients 
compared to the controls. The CM specific IgE 
expression was comparable among both patient 
groups. The mean IgE values were 21.9 ± 20.4 
IU/ml [median and IQR are 20.0 and 38.0] for the 
first group and 22.5 ± 25.1 IU/ml [median and IQR 
are 17.0 and 38.3] for the second group (z = - 0.46, 
p>0.05).  
When we classified the autistic children into 
categories according to their CARS test results, no 
significant differences were detected initially (χ2 = 
0.21, p>0.05). Nevertheless, statistical significance 
between the two groups was evident after the 
follow up period (χ2 = 7.07, p<0.05). More patients 
from the group that underwent CM elimination diet 
belong to categories 0 and 1 compared to categories 
1 and 2 in the second group by the end of the trial. 
Additionally, tables (3) and (4) show that 45.5% of 
patients who were on CM elimination diet went one 
CARS category down compared to only 36.4% 
from the second group. 
 
 
Table 1. The CARS test, mental age, social age and IQ of the two studied groups upon enrollment 
and after follow up. 
 Group I 
Patients on elimination diet 
Group II 
Patients without diet elimination t/z* p 
Initial CARS 36.6±3.3 [37.0(5.0)] 38.1±4.0 [38.5 (8.0 )] -0.99 >0.05 
FU CARS 30.8±2.9 [30.0(4.5)] 35.6±3.6 [35.0 (7.0 )] -3.47 <0.01 
ROC of CARS  15.7±2.9 [16.2 (4.6)] 6.6±3.8 [7.1 (6.2)] -6.39 <0.001 
Initial language 1.9±2.1 [1.0 (1.3)] 1.4±1.58 [0.8(0.3)] -0.97* >0.05 
FU language 2.4±1.9 [2.0(2.0)] 1.5±1.6 [1.0(0.3)] -2.19* <0.05 
ROC of language 49.9±39.6 [33.3(100.0)] 7.6±17.7 [0.0(0.0)] -2.50* <0.05 
Initial MA  2.2±1.0 [2.2(2.0)] 2.6±1.4 [2.0(2.0)] -0.72 >0.05 
FU  MA 2.4±1.1 [2.5 (1.8)] 2.6±1.5 [2.0(3.2)] -0.35 >0.05 
ROC of MA 10.3±14.4 [8.3 (14.3)] 0.5±12.4 [0.0(10.1)] -2.48* <0.05 
Initial SA 2.3±1.0 [2.5 (2.1)] 3.0±1.5  [2.3(3.3)] -1.26 >0.05 
FU SA 2.6 ±1.0 [2.9 (2.1)] 3.1±1.6 [2.4 (3.3)] -0.59 >0.05 
ROC of SA 15.0±8.4 [11.3(7.7)] 3.3±8.9 [0.0(7.6)]  3.17 <0.01 
Initial IQ 37.9±9.1[38.0 (12.0)] 37.2±10.1 [38.0(15.0)]  0.18 >0.05 
FU IQ 39.4±9.9 [40.0 (15.0)] 37.0±13.2[35.0(18.0)]  0.48 >0.05 
ROC of IQ 4.0±11.4 [3.8(5.3)] 2.4±10.4[0.0(10.5)] -1.92* <0.05 
*Non-parametric data as detected by Kolmogorov-Smirnov test. Test of significance used is Mann Whitney test. Data 
are presented as mean ± SD [median (IQR)]. 
CARS: childhood autism rating scale; FU: follow up; IQ: intelligence quotient; MA; mental age; ROC: rate of change; 
SA: social age. 
 
Table 2. Comparison between the initial and the follow up CARS test, mental age, social age and 
IQ in each studied group.  
 Group I 
Patients on elimination diet 
 Group II  
Patients without diet elimination 





























































*Non-parametric data as detected by Kolmogorov-Smirnov test. Test of significance used is Wilcoxon Signed 
Ranks test. Data are presented as mean ± SD [median (IQR)]. 
CARS: childhood autism rating scale; IQ: intelligence quotient; MA: mental age; SA: social age. 
 






















































Figure 1. Serum CM specific IgE level in autistic children compared to the 
controls. 
The boxes enclose the interquartile ranges (IQR) which are between the 25th and the 75th 
percentiles. The horizontal line inside the box represents the median and the whiskers 
represent the non outliner or extreme maximum and minimum values. The closed small 
squares represent extreme values (more than 3 IQR) and small open circles represent the 
outlier values (between 1.5 and 3 IQR). 
 
 
Table 3. Changes in CARS categories upon follow up of the patients on 
CM elimination diet. 
 CARS Category after 







Count 3  3 
% within CARSB 100.0%  100.0% 
% within CARSA 100.0%  27.3% 
2 
Count  8 8 
% within CARSB  100.0% 100.0% 
% within CARSA  100.0% 72.7% 
Total 
 Count 3 8 11 
% within CARSB 27.3% 72.7% 100.0% 
% within CARSA 100.0% 100.0% 100.0% 
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Table 4. Changes in CARS categories upon follow up of the patients 
who were not on CM elimination diet. 
 CARS Category after 







Count 4  4 
% within CARSB 100.0%  100.0% 
% within CARSA 57.1%  36.4% 
2 
Count 3 4 7 
% within CARSB 42.9% 57.1% 100.0% 
% within CARSA 42.9% 100.0% 63.6% 
Total 
 Count 7 4 11 
% within CARSB 63.6% 36.4% 100.0% 
% within CARSA 100.0% 100.0% 100.0% 






The significant improvement in the autistic children 
who were subjected to CM elimination diet as 
demonstrated by a significantly higher rate of 
change of CARS test results, language, social age, 
mental age and IQ compared to the rest of the 
studied sample enforces the potential adverse role 
of CM proteins in the etiopathogenesis of autism or 
at least in the progression of clinical severity. The 
use of an elimination diet to treat autism was 
previously demonstrated by Garvey17, who weighed 
the potential benefits against some of the practical 
difficulties of keeping to a strict exclusion diet. The 
improvement on CM elimination in our series 
agrees with Lucarelli et al4 who noticed a marked 
improvement in the behavioral symptoms of 36 
autistic patients after a period of 8 weeks on CM 
free diet. Yet, this study included elimination of 
other foods which gave positive skin test results in 
their series.  
Dohan18 hypothesized that there is a defect in 
the intestinal barrier of schizophrenic patients that 
allows passage of neuroactive peptides of food 
origin into the blood and then into the cerebrospinal 
fluid to interfere directly with the CNS function. 
This hypothesis may be applicable to autistic 
patients as well because one member of the family 
of casomorphins, ß-casomorphins-7, is reported to 
be elevated in the urine of autistic patients19. From 
this toxic theory we shift to an immune theory 
suggested by Vojdani and colleagues20. They 
explained a mechanism by which bacterial 
infections and milk antigens may modulate 
autoimmune responses in autism. In their series, 
autistic children showed the highest levels of IgG, 
IgM and IgA auto-antibodies against nine different 
neuron-specific antigens as well as three cross-
reactive peptides including milk protein. They 
suggested that these antibodies may have been 
synthesized as a result of an alteration in the blood-
brain barrier. This barrier failure promotes access of 
preexisting T-cells and CNS antigens to 
immunocompetent cells, which may start a vicious 
cycle.  
The current study revealed significantly higher 
IgE against CMP in autistic children compared to 
the controls. This finding comes in agreement with 
Lucarelli et al4 and it further emphasizes the role of 
the immune system in the occurrence of adverse 
reactions to CMP in ASD children. Additionally, 
Ashwood and coworkers21 reported diffuse mucosal 
immunopathology in some ASD children and 
highlighted the potential for benefit from dietary 
therapies. Further studies that include oral food 
challenges with CM are needed to verify the role of 
allergy or intolerance in this context. 
In conclusion, autistic children showed 
improvement in language, cognition and behavioral 
capabilities upon CM elimination and they 
demonstrated high levels of specific IgE antibodies 
against CMP suggesting an allergic element in the 
pathogenesis of this potential adverse reaction to 
CM.  The findings are limited by the sample size 
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and further trials are indicated. However, our data 
re-enforce the concept of involvement of CM in the 
etiology or at least the progression of autistic 
features. We recommend trials of CM elimination 
diet and re-challenge in autistic children with 
replacement by safe alternatives hoping for better 
achievement during their interventional programs. 
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